H.R. 8333 · 118th Congress

BIOSECURE Act

Introduced on May 10, 2024 by Brad R. Wenstrup (R-OH-2). 14 cosponsors, 7 of them from another party. Latest action (Sep 10, 2024): Received in the Senate and Read twice and referred to the Committee on Homeland Security and Governmental Affairs.

Stage
Passed one chamber
Introduced
May 10, 2024
Cosponsors
14
7 from the other party
Policy area
Health
Open in the Congress explorerCongress.govAlert me

Progress

The furthest stage the measure reached. Simple and concurrent resolutions do not go to the President.

  1. Introduced
  2. Reported by committee
  3. Passed one chamber
  4. 4Passed both chambers
  5. 5Sent to the President
  6. 6Became law

Official title

To prohibit contracting with certain biotechnology providers, and for other purposes.

Subjects

  • Asia
  • China
  • Congressional oversight
  • Diplomacy, foreign officials, Americans abroad
  • Foreign and international corporations
  • Government employee pay, benefits, personnel management
  • Government information and archives
  • Government lending and loan guarantees
  • Government studies and investigations
  • Health technology, devices, supplies
  • Public contracts and procurement

Summary

The Congressional Research Service has not summarized this measure yet.

Sponsor and cosponsors

Cosponsors by party as of the day they signed on. Original cosponsors signed on the day of introduction.

Brad R. WenstrupR-OH-2Sponsor

Democrats · 7

Republicans · 7

Roll calls

Recorded votes on the measure. Most measures move by voice vote or unanimous consent, which record no individual positions.

  1. On Motion to Suspend the Rules and Pass, as Amended
    Sep 9, 2024· House· Passage· Passed 306–81

History

Every action as published, oldest first. Roll calls link to how each member voted.

  1. May 10, 2024Introduced in House
  2. May 10, 2024Introduced in House
  3. May 10, 2024 · HouseReferred to the Committee on Oversight and Accountability, and in addition to the Committee on Intelligence (Permanent Select), for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  4. May 10, 2024 · HouseReferred to the Committee on Oversight and Accountability, and in addition to the Committee on Intelligence (Permanent Select), for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  5. May 15, 2024 · HouseCommittee Consideration and Mark-up Session Held
  6. May 15, 2024 · HouseOrdered to be Reported in the Nature of a Substitute by the Yeas and Nays: 40 - 1.
  7. Sep 9, 2024 · HouseMr. Comer moved to suspend the rules and pass the bill, as amended.
  8. Sep 9, 2024 · HouseConsidered under suspension of the rules. (consideration: CR H5051-5058)
  9. Sep 9, 2024 · HouseDEBATE - The House proceeded with forty minutes of debate on H.R. 8333.
  10. Sep 9, 2024 · HouseAt the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
  11. Sep 9, 2024 · HouseConsidered as unfinished business. (consideration: CR H5081-5082)
  12. Sep 9, 2024Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 306 - 81 (Roll no. 402). (text: CR H5051-5052)House · Roll call 402
  13. Sep 9, 2024 · HouseOn motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 306 - 81 (Roll no. 402). (text: CR H5051-5052)House · Roll call 402
  14. Sep 9, 2024 · HouseMotion to reconsider laid on the table Agreed to without objection.
  15. Sep 10, 2024 · SenateReceived in the Senate and Read twice and referred to the Committee on Homeland Security and Governmental Affairs.

Committees

Committees and subcommittees the measure was referred to.

Agencies in its committees' jurisdiction

Analisa's mapping of committee jurisdiction to federal agencies; the bill may touch others, or none of these.

Who lobbied on it

Organizations whose lobbying reports (LD-2) name this measure. Spending is what they reported for those quarters on all issues, not on this measure alone.

  1. FUJIFILM Holdings America Corporation7 reports
    $485K reported (all issues)
  2. WUXI BIOLOGICS USA LLC6 reports
    $295K reported (all issues)
  3. AMGEN INC.3 reports
    $8.3M reported (all issues)Federal contractor: AMGEN INC.AI match · 99%
  4. Heritage Action for America3 reports
    $590K reported (all issues)
  5. ILLUMINA, INC.3 reports
    $950K reported (all issues)Federal contractor: ILLUMINA, INC.$21.9M in contracts, FY2026AI match · 100%
  6. PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA3 reports
    $7.6M reported (all issues)
  7. AGC America, Inc.2 reports
    $230K reported (all issues)
  8. FDD Action2 reports
    $300K reported (all issues)
  9. GSK (fka GLAXOSMITHKLINE INC.)2 reports
    $2.4M reported (all issues)
  10. HARVARD UNIVERSITY--PRESIDENT AND FELLOWS OF HARVARD COLLEGE2 reports
    $320K reported (all issues)
  11. SMITH & NEPHEW, INC.2 reports
    $870K reported (all issues)Federal contractor: SMITH & NEPHEW INCAI match · 100%
  12. BEIGENE USA INC.1 report
    $160K reported (all issues)
  13. BROWN UNIVERSITY1 report
    $70K reported (all issues)Federal contractor: BROWN UNIVERSITY$1M in contracts, FY2026AI match · 100%
  14. IQVIA Holdings, Inc.1 report
    $60K reported (all issues)
  15. The United States Pharmacopeial Convention1 report
    $60K reported (all issues)
  16. Vanderbilt University1 report
    $40K reported (all issues)Federal contractor: VANDERBILT UNIVERSITY$1.6M in contracts, FY2026AI match · 100%

Reports filed in 2024, 2025.

Sources and method

Every figure on this page traces to these records.

  • Bill status: bills and resolutions, sponsors, actions, subjects and CRS summaries (U.S. Government Publishing Office (GovInfo), from Congress.gov (Library of Congress))GovInfo Bill Status bulk data (Congress.gov; summaries by the Congressional Research Service) · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Members of Congress, their terms, committees and identifiers (The @unitedstates project (from the Biographical Directory of the U.S. Congress, the House and the Senate))unitedstates/congress-legislators: legislators, committees and current committee membership · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: CC0 1.0 (public domain dedication)
  • House roll-call votes (Office of the Clerk, U.S. House of Representatives)Office of the Clerk, U.S. House of Representatives, roll-call vote records · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Senate roll-call votes and DW-NOMINATE scores (Voteview (UCLA Department of Political Science))Lewis, Jeffrey B., Keith Poole, Howard Rosenthal, Adam Boche, Aaron Rudkin, and Luke Sonnet (2026). Voteview: Congressional Roll-Call Votes Database. https://voteview.com/ · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: Free to use with the required citation
  • Lobbying disclosures (LD-1 registrations, LD-2 quarterly reports, LD-203 contribution reports) (Clerk of the U.S. House of Representatives)Clerk of the House, Lobbying Disclosure Act filings (organizations only; lobbyists' names are not loaded) · data current to Oct 6, 2026 · loaded Oct 6, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Positions are shown only where a roll call recorded them; voice votes and unanimous consent record none.
  • Money and votes are shown side by side; neither explains the other.